News Focus
News Focus
icon url

The Danish Dude

04/23/21 7:39 AM

#371822 RE: MI Dendream #371815

Good point. Likewise it also explains that the one bidding, has an interest, that the SP price doesn’t go up, which explains why people like AF is still at large, at every possible turn. Why ambulance chasers are called in. And why people without a financial risk, continue to contribute with board fudding.
icon url

Smokey21

04/23/21 7:42 AM

#371824 RE: MI Dendream #371815

I’m of the opinion that releasing top line at ASCO has always been the plan since data lock and that the publication excuse was a good smokescreen to use.
icon url

learningcurve2020

04/23/21 8:21 AM

#371834 RE: MI Dendream #371815

More likely scenario ASCO will pass without a peep, LL will chat about many ongoing future treatments. The company will probably start spreading the word that tld will only be released if there's a journal willing to print it. Tld ould also be kept "secret" because of the need to remain unbiased for a potential trial redux. So many possible excuses???
icon url

tryn2

04/23/21 9:59 AM

#371872 RE: MI Dendream #371815

JUNE 3, 2021 at 5:00 PM ET
Late-Breaking Abstracts (LBAs) Released on ASCO.org

JUNE 4-8, 2021
ASCO Annual Meeting

JULY 6, 2021
Exhibits, Industry Expert Theater, Pharmaceutical Pipeline Directory, and Clinical Trials Directory Close

So when do you think we get the TLD presser???